RadNet Cash Flow from Investing Activities 2010-2024 | RDNT

RadNet cash flow from investing activities from 2010 to 2024. Cash flow from investing activities can be defined as the total change in cash resulting from a companies investments
RadNet Annual Cash Flow Investing
(Millions of US $)
2024 $-233
2023 $-201
2022 $-247
2021 $-222
2020 $-126
2019 $-99
2018 $-147
2017 $-79
2016 $-65
2015 $-97
2014 $-54
2013 $-51
2012 $-87
2011 $-88
2010 $-101
2009 $-36
Sector Industry Market Cap Revenue
Medical MED-OUTP/HM CRE $4.004B $1.830B
RadNet, Inc., is a national market leader providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers. RadNet offers to its patients and referring physicians the full spectrum of diagnostic imaging exams, including PET/CT, MRI, CT, Nuclear Medicine, Mammography, Ultrasound and X-ray, as well as numerous other procedures. RadNet utilizes best of breed technology to appropriately serve the medical communities in which it operates.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) US $19.865B 19.58
Encompass Health (EHC) US $11.747B 24.92
DaVita (DVA) US $10.848B 14.40
Chemed (CHE) US $8.418B 26.46
Option Care Health (OPCH) US $5.395B 24.05
Elanco Animal Health (ELAN) US $4.840B 10.71
Amedisys (AMED) US $3.151B 21.19
LifeStance Health (LFST) US $2.644B 0.00
Addus HomeCare (ADUS) US $1.932B 22.11
Astrana Health (ASTH) US $1.822B 36.51
U.S Physical Therapy (USPH) US $1.099B 28.03
Aveanna Healthcare Holdings (AVAH) US $0.944B 0.00
Pennant (PNTG) US $0.927B 37.07
Atai Life Sciences (ATAI) DE $0.300B 0.00
Daxor (DXR) US $0.036B 0.00
Ontrak (OTRK) US $0.006B 0.00
MEDIROM Healthcare Technologies (MRM) JP $0.005B 0.00
Psychemedics (PMD) US $0.000B 0.00